Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
VaccinesInfectious Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 1076641

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1076641

Meningococcal Vaccines Market Size, Share & Trends Analysis Report By Brand (Menactra, Menveo, Bexsero, Trumenba, Nimenrix), By Type, By Serotype, By Age Group, By Sales Channel, By Region and Segment Forecasts, 2022 - 2030

PUBLISHED:
PAGES: 163 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Meningococcal Vaccines Market Growth & Trends:

The global meningococcal vaccines market size is expected to reach USD 4.92 billion by 2030, registering a CAGR of 6.2%, according to a new report by Grand View Research, Inc. Increasing prevalence of meningitis is one of the major factors attributed to the market growth. For instance, according to ECDC, it was estimated that in 2017, 3,221 confirmed cases were observed in EU member states, wherein 58% cases were found in the U.K., France, Spain, and Germany. Moreover, a high incidence of meningitis disease is found in the "meningitis belt" of sub-Saharan Africa, and approximately 30,000 cases are reported every year in this region.

In addition, rising FDA approval for meningococcal vaccines is expected to boost the growth. For instance, in April 2020, Sanofi received FDA approval for its MenQuadfi Meningococcal Conjugate Vaccine for the prevention of invasive meningococcal disorders in individuals at least two years old. The increase in approval of novel vaccines is expected to improve meningococcal prevention which in turn, is anticipated to drive the market.

Initiatives undertaken by the government to combat the rising incidence of the disease are anticipated to boost the meningococcal vaccine market growth. For instance, from April 2019, Nimenrix was made available for free as a part of the National Immunization Program (NIP) in Australia for the age group 15 to 19 years. Nimenrix is a quadrivalent meningococcal vaccine that targets serogroups A, C, W & Y.

According to WHO, as of 2021, 24 of the 26 nations in the meningitis belt have introduced mass preventive campaigns targeting the age of 1 to 29 years. Moreover, around 13 nations have undertaken the vaccine in their national routine immunization programs. Such initiatives undertaken by countries having high disease burdens are expected to boost the market growth.

Non-profit organizations entering into strategic initiatives such as partnering, alliances, and others to improve access to new vaccines for vulnerable children are anticipated to drive the market. For instance, in September 2021, WHO and its partners announced the first-ever global strategy to defeat meningitis. This initiative aims to reduce epidemics of bacterial meningitis. Under this strategy, WHO goals to save more than 200,000 lives annually.

The availability of vaccines at lower prices in countries with an increasing prevalence of the meningococcal disease is anticipated to fuel the revenue of the manufacturers and drive the meningococcal vaccine market. For instance, under Meningitis Vaccine Project, MenAfriVac costs less than USD 0.5 per dose.

Meningococcal Vaccines Market Report Highlights:

  • Quadrivalent vaccines dominated the type segment owing to their ability to target four serogroups and the strong presence of vaccines such as Menveo, Menactra, and Nimenrix
  • The infants (0-2 years) segment accounted for the significant revenue share, by age group, in 2021. The increasing prevalence of meningitis in the age group 9 months to 11 years contributed to the segment growth
  • Asia Pacific region is expected to witness the highest CAGR over the forecast period. High unmet needs, rising healthcare expenditure, and a large population base in this region are likely to bolster the market
Show more
Product Code: GVR-4-68039-045-9

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 List Of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective 1
    • 1.8.2 Objective 2
    • 1.8.3 Objective 3
    • 1.8.4 Objective 4
  • 1.9 List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1 Market Summary

Chapter 3. Meningococcal Vaccines Market Variables, Trends, And Scope

  • 3.1 Penetration And Growth Prospect Mapping
  • 3.2 Product Pipeline Analysis
  • 3.3 Regulatory Framework
    • 3.3.1 North America
    • 3.3.2 Europe
    • 3.3.3 Asia Pacific
    • 3.3.4 Latin America
    • 3.3.5 Middle East & Africa
  • 3.4 Market Driver Analysis
    • 3.4.1 Rising Incidence Of Meningitis
    • 3.4.2 Rising R&D In Meningococcal Vaccines
    • 3.4.3 Increasing Immunization Programs And Government Initiatives
    • 3.4.4 Growing Support By Healthcare Services In Providing Low-Cost Meningococcal Vaccine
  • 3.5 Market Restraint Analysis
    • 3.5.1 High-Cost Associated With Storage And Supply Of Vaccines
    • 3.5.2 Challenges Associated With Vaccine Development
  • 3.6 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.7 Porter's Five Forces Analysis
  • 3.8 Major Deals And Strategic Alliances Analysis
    • 3.8.1 New Product Launches
    • 3.8.2 Mergers And Acquisitions
    • 3.8.3 Expansion
    • 3.8.4 Partnerships
    • 3.8.5 Marketing And Promotions
    • 3.8.6 Market Entry Strategies

Chapter 4. Meningococcal Vaccines Market: Segment Analysis, By Type 2017 - 2030 (USD Million)

  • 4.1 Definition And Scope
  • 4.2 Type Market Share Analysis, 2021 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Meningococcal Vaccines Market, By Type, 2017 To 2030
  • 4.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
    • 4.5.1 Bivalent
      • 4.5.1.1 Bivalent Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 4.5.2 Quadrivalent
      • 4.5.2.1 Quadrivalent Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 4.5.3 Others
      • 4.5.3.1 Others Market Estimates And Forecast 2017 - 2030 (USD Million)

Chapter 5. Meningococcal Vaccines Market: Segment Analysis, By Brand 2017 - 2030 (USD Million)

  • 5.1 Definition And Scope
  • 5.2 Brand Market Share Analysis, 2020 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Meningococcal Vaccines Market, By Brand, 2017 To 2030
  • 5.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
    • 5.5.1 Menactra
      • 5.5.1.1 Menactra Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 5.5.2 Menveo
      • 5.5.2.1 Menveo Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 5.5.3 Nimenrix
      • 5.5.3.1 Nimenrix Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 5.5.4 Trumenba
      • 5.5.4.1 Trumenba Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 5.5.5 BEXSERO
      • 5.5.5.1 Bexsero Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 5.5.6 OTHERS
      • 5.5.6.1 Others Market Estimates And Forecast 2017 - 2030 (USD Million)

Chapter 6. Meningococcal Vaccines Market: Segment Analysis, By Age Group 2017 - 2030 (USD Million)

  • 6.1 Definition And Scope
  • 6.2 Age Group Market Share Analysis, 2021 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Meningococcal Vaccines Market, By Age Group, 2017 To 2030
  • 6.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
    • 6.5.1 INFANTS (0 - 2 YEARS)
      • 6.5.1.1 Infants Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 6.5.2 CHILDREN AND ADULTS (2 YEARS AND ABOVE)
      • 6.5.2.1 Children And Adults Market Estimates And Forecast 2017 - 2030 (USD Million)

Chapter 7. Meningococcal Vaccines Market: Segment Analysis, By Serotype 2017 - 2030 (USD Million)

  • 7.1 Definition And Scope
  • 7.2 Serotype Market Share Analysis, 2021 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global Meningococcal Vaccines Market, By Serotype, 2017 To 2030
  • 7.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
    • 7.5.1 SEROTYPE A
      • 7.5.1.1 Serotype A Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 7.5.2 SEROTYPE B
      • 7.5.2.1 Serotype B Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 7.5.3 SEROTYPE C
      • 7.5.3.1 Serotype C Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 7.5.4 SEROTYPE W-135
      • 7.5.4.1 Serotype W Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 7.5.5 SEROTYPE Y
      • 7.5.5.1 Serotype Y Market Estimates And Forecast 2017 - 2030 (USD Million)

Chapter 8. Meningococcal Vaccines Market: Segment Analysis, By Sales Channel 2017 - 2030 (USD Million)

  • 8.1 Definition And Scope
  • 8.2 Sales Channel Market Share Analysis, 2021 & 2030
  • 8.3 Segment Dashboard
  • 8.4 Global Meningococcal Vaccines Market, By Sales Channel, 2017 To 2030
  • 8.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
    • 8.5.1 PRIVATE
      • 8.5.1.1 Private Market Estimates And Forecast 2017 - 2030 (USD Million)
    • 8.5.2 PUBLIC
      • 8.5.2.1 Public Market Estimates And Forecast 2017 - 2030 (USD Million)

Chapter 9. Meningococcal Vaccines Market: Segment Analysis, By Region 2017 - 2030 (USD Million)

  • 9.1 Definition & Scope
  • 9.2 Regional Market Share Analysis, 2021 & 2030
  • 9.3 Regional Market Dashboard
  • 9.4 Regional Market Snapshot
  • 9.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
    • 9.5.1 NORTH AMERICA
      • 9.5.1.1 North America Market Estimates And Forecasts 2017 - 2030 (USD Million)
      • 9.5.1.2 U.S.
      • 9.5.1.2.1 U.S. Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.1.3 Canada
      • 9.5.1.3.1 Canada Market Estimate And Forecasts 2017 - 2030 (USD Million)
    • 9.5.2 EUROPE
      • 9.5.2.1 Europe Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.2 Germany
      • 9.5.2.2.1 Germany Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.3 U.K.
      • 9.5.2.3.1 U.K. Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.4 France
      • 9.5.2.4.1 France Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.5 Spain
      • 9.5.2.5.1 Spain Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.6 Italy
      • 9.5.2.6.1 Italy Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.7 Russia
      • 9.5.2.7.1 Russia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.8 Belarus
      • 9.5.2.8.1 Belarus Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.9 Georgia
      • 9.5.2.9.1 Georgia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.2.10 Moldova
      • 9.5.2.10.1 Moldova Market Estimate And Forecasts 2017 - 2030 (USD Million)
    • 9.5.3 ASIA PACIFIC
      • 9.5.3.1 Asia Pacific Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.2 Japan
      • 9.5.3.2.1 Japan Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.3 China
      • 9.5.3.3.1 China Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.4 India
      • 9.5.3.4.1 India Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.5 South Korea
      • 9.5.3.5.1 South Korea Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.6 Australia
      • 9.5.3.6.1 Australia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.7 Singapore
      • 9.5.3.7.1 Singapore Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.8 Thailand
      • 9.5.3.8.1 Thailand Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.9 Vietnam
      • 9.5.3.9.1 Vietnam Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.10 Malaysia
      • 9.5.3.10.1 Malaysia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.11 Indonesia
      • 9.5.3.11.1Indonesia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.12 Kazakhstan
      • 9.5.3.12.1Kazakhstan Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.13 Kyrgyzstan
      • 9.5.3.13.1Kyrgyzstan Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.14 Armenia
      • 9.5.3.14.1Armenia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.15 Azerbaijan
      • 9.5.3.15.1Azerbaijan Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.16 Tajikistan
      • 9.5.3.16.Tajikistan Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.17 Turkmenistan
      • 9.5.3.17.1 Turkmenistan Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.3.18 Uzbekistan
      • 9.5.3.18.1Uzbekistan Market Estimate And Forecasts 2017 - 2030 (USD Million)
    • 9.5.4 LATIN AMERICA
      • 9.5.4.1 Latin America Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.2 Brazil
      • 9.5.4.2.1 Brazil Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.3 Mexico
      • 9.5.4.3.1 Mexico Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.4 Argentina
      • 9.5.4.4.1 Argentina Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.5 Chile
      • 9.5.4.5.1 Chile Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.6 Cuba
      • 9.5.4.6.1 Cuba Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.7 Ecuador
      • 9.5.4.7.1 Ecuador Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.8 Peru
      • 9.5.4.8.1 Peru Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.9 Colombia
      • 9.5.4.9.1 Colombia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.4.10 Venezuela
      • 9.5.4.10.1 Venezuela Market Estimate And Forecasts 2017 - 2030 (USD Million)
    • 9.5.5 MIDDLE EAST & AFRICA
      • 9.5.5.1 Middle-East And Africa Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.2 South Africa
      • 9.5.5.2.1 South Africa Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.3 Saudi Arabia
      • 9.5.5.3.1 Saudi Arabia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.4 UAE
      • 9.5.5.4.1 UAE Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.5 Algeria
      • 9.5.5.5.1 Algeria Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.6 Egypt
      • 9.5.5.6.1 Egypt Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.7 Tunisia
      • 9.5.5.7.1 Tunisia Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.8 Iran
      • 9.5.5.8.1 Iran Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.9 Turkey
      • 9.5.5.9.1 Turkey Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.10 Iraq
      • 9.5.5.10.1Iraq Market Estimate And Forecasts 2017 - 2030 (USD Million)
      • 9.5.5.11 Morocco
      • 9.5.5.11.1Morocco Market Estimate And Forecasts 2017 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 10.1.1 ANSOFF MATRIX
    • 10.1.2 COMPANY/COMPETITION CATEGORIZATION (KEY INNOVATORS, MARKET LEADERS, EXPANSION)
    • 10.1.3 INNOVATORS
  • 10.2 Vendor Landscape
    • 10.2.1 LIST OF KEY DISTRIBUTORS AND CHANNEL PARTNERS
    • 10.2.2 KEY COMPANY MARKET SHARE ANALYSIS, 2021
  • 10.3 Public Companies
    • 10.3.1 COMPANY MARKET POSITION ANALYSIS
    • 10.3.2 COMPETITIVE DASHBOARD ANALYSIS
  • 10.4 Private Companies
    • 10.4.1 KEY EMERGING COMPANIES/TECHNOLOGY DISRUPTORS/INNOVATORS
    • 10.4.2 REGIONAL NETWORK MAP
  • 10.5 Strategy Framework
  • 10.6 Company Profile
    • 10.6.1 SANOFI
      • 10.6.1.1 Company Overview
      • 10.6.1.2 Financial Performance
      • 10.6.1.3 Product Benchmarking
      • 10.6.1.4 Strategic Initiatives
    • 10.6.2 MERCK & CO., INC.
      • 10.6.2.1 Company Overview
      • 10.6.2.2 Financial Performance
      • 10.6.2.3 Product Benchmarking
      • 10.6.2.4 Strategic Initiatives
    • 10.6.3 GLAXOSMITHKLINE PLC
      • 10.6.3.1 Company Overview
      • 10.6.3.2 Financial Performance
      • 10.6.3.3 Product Benchmarking
      • 10.6.3.4 Strategic Initiatives
    • 10.6.4 SERUM INSTITUTE OF INDIA PVT. LTD.
      • 10.6.4.1 Company Overview
      • 10.6.4.2 Product Benchmarking
      • 10.6.4.3 Strategic Initiatives
    • 10.6.5 PFIZER, INC.
      • 10.6.5.1 Company Overview
      • 10.6.5.2 Financial Performance
      • 10.6.5.3 Product Benchmarking
      • 10.6.5.4 Strategic Initiatives
    • 10.6.6 WALWAX BIOTECHNOLOGY CO., LTD
      • 10.6.6.1 Company Overview
      • 10.6.6.2 Product Benchmarking
      • 10.6.6.3 Strategic Initiatives
    • 10.6.7 PETROVAX
      • 10.6.7.1 Company Overview
      • 10.6.7.2 Product Benchmarking
      • 10.6.7.3 Strategic Initiatives
Show more
Product Code: GVR-4-68039-045-9

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Product Pipeline
  • Table 4 CDC Vaccine Price List
  • Table 5 List of Key Emerging Companies /Technology Disruptors/Innovators
  • Table 6 America Meningococcal Vaccines Market, By Country 2017 - 2030 (USD Million)
  • Table 7 North America Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 8 North America Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 9 North America Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 10 North America Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 11 North America Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 12 U.S. Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 13 U.S. Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 14 U.S. Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 15 U.S. Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 16 U.S. Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 17 Canada Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 18 Canada Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 19 Canada Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 20 Canada Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 21 Canada Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 22 Europe Meningococcal Vaccines Market, By Country 2017 - 2030 (USD Million)
  • Table 23 Europe Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 24 Europe Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 25 Europe Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 26 Europe Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 27 Europe Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 28 Germany Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 29 Germany Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 30 Germany Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 31 Germany Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 32 Germany Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 33 U.K. Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 34 U.K. Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 35 U.K. Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 36 U.K. Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 37 U.K. Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 38 France Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 39 France Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 40 France Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 41 France Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 42 France Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 43 Italy Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 44 Italy Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 45 Italy Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 46 Italy Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 47 Italy Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 48 Spain Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 49 Spain Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 50 Spain Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 51 Spain Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 52 Spain Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 53 Russia Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 54 Russia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 55 Russia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 56 Russia Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 57 Russia Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 58 Belarus Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 59 Belarus Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 60 Belarus Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 61 Belarus Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 62 Belarus Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 63 Georgia Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 64 Georgia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 65 Georgia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 66 Georgia Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 67 Georgia Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 68 Moldova Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 69 Moldova Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 70 Moldova Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 71 Moldova Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 72 Moldova Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 73 Asia Pacific Meningococcal Vaccines Market, By Country 2017 - 2030 (USD Million)
  • Table 74 Asia Pacific Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 75 Asia Pacific Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 76 Asia Pacific Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 77 Asia Pacific Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 78 Asia Pacific Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 79 Japan Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 80 Japan Meningococcal Vaccines Market, By Brand 2017-2030 (USD Million)
  • Table 81 Japan Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 82 Japan Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 83 Japan Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 84 China Meningococcal Vaccines Market, By Product 2017 - 2030 (USD Million)
  • Table 85 China Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 86 China Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 87 China Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 88 China Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 89 India Meningococcal Vaccines Market, By Product 2017 - 2030 (USD Million)
  • Table 90 India Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 91 India Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 92 India Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 93 India Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 94 Australia Meningococcal Vaccines Market, By Product 2017 - 2030 (USD Million)
  • Table 95 Australia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 96 Australia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 97 Australia Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 98 Australia Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 99 Singapore Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 100 Singapore Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 101 Singapore Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 102 Singapore Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 103 Singapore Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 104 South Korea Meningococcal Vaccines Market, By Type 2017-2030 (USD Million)
  • Table 105 South Korea Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 106 South Korea Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 107 South Korea Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 108 South Korea Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 109 Thailand Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 110 Thailand Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 111 Thailand Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 112 Thailand Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 113 Thailand Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 114 Vietnam Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 115 Vietnam Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 116 Vietnam Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 117 Vietnam Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 118 Vietnam Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 119 Malaysia Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 120 Malaysia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 121 Malaysia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 122 Malaysia Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 123 Malaysia Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 124 Indonesia Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 125 Indonesia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 126 Indonesia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 127 Indonesia Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 128 Indonesia Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 129 Kazakhstan Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 130 Kazakhstan Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 131 Kazakhstan Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 132 Kazakhstan Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 133 Kazakhstan Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 134 Kyrgyzstan Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 135 Kyrgyzstan Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 136 Kyrgyzstan Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 137 Kyrgyzstan Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 138 Kyrgyzstan Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 139 Armenia Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 140 Armenia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 141 Armenia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 142 Armenia Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 143 Armenia Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 144 Azerbaijan Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 145 Azerbaijan Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 146 Azerbaijan Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 147 Azerbaijan Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 148 Azerbaijan Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 149 Tajikistan Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 150 Tajikistan Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 151 Tajikistan Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 152 Tajikistan Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 153 Tajikistan Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 154 Turkmenistan Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 155 Turkmenistan Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 156 Turkmenistan Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 157 Turkmenistan Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 158 Turkmenistan Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 159 Uzbekistan Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 160 Uzbekistan Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 161 Uzbekistan Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 162 Uzbekistan Meningococcal Vaccines Market, By Serotype 2017-2030 (USD Million)
  • Table 163 Uzbekistan Meningococcal Vaccines Market, By Sales Channel 2017-2030 (USD Million)
  • Table 164 Latin America Meningococcal Vaccines Market, By Country 2017 - 2030 (USD Million)
  • Table 165 Latin America Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 166 Latin America Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 167 Latin America Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 168 Latin America Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 169 Latin America Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 170 Brazil Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 171 Brazil Meningococcal Vaccines Market, By Brand 2017-2030 (USD Million)
  • Table 172 Brazil Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 173 Brazil Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 174 Brazil Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 175 Mexico Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 176 Mexico Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 177 Mexico Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 178 Mexico Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 179 Mexico Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 180 Argentina Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 181 Argentina Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 182 Argentina Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 183 Argentina Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 184 Argentina Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 185 Chile Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 186 Chile Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 187 Chile Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 188 Chile Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 189 Chile Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 190 Cuba Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 191 Cuba Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 192 Cuba Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 193 Cuba Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 194 Cuba Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 195 Ecuador Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 196 Ecuador Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 197 Ecuador Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 198 Ecuador Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 199 Ecuador Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 200 Peru Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 201 Peru Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 202 Peru Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 203 Peru Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 204 Peru Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 205 Colombia Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 206 Colombia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 207 Colombia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 208 Colombia Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 209 Colombia Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 210 Venezuela Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 211 Venezuela Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 212 Venezuela Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 213 Venezuela Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 214 Venezuela Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 215 Middle East & Africa Meningococcal Vaccines Market, By Country 2017 - 2030 (USD Million)
  • Table 216 Middle East & Africa Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 217 Middle East & Africa Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 218 Middle East & Africa Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 219 Middle East & Africa Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 220 Middle East & Africa Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 221 Saudi Arabia Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 222 Saudi Arabia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 223 Saudi Arabia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 224 Saudi Arabia Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 225 Saudi Arabia Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 226 South Africa Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 227 South Africa Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 228 South Africa Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 229 South Africa Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 230 South Africa Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 231 UAE Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 232 UAE Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 233 UAE Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 234 UAE Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 235 UAE Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 236 Algeria Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 237 Algeria Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 238 Algeria Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 239 Algeria Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 240 Algeria Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 241 Egypt Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 242 Egypt Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 243 Egypt Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 244 Egypt Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 245 Egypt Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 246 Tunisia Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 247 Tunisia Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 248 Tunisia Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 249 Tunisia Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 250 Tunisia Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 251 Iran Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 252 Iran Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 253 Iran Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 254 Iran Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 255 Iran Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 256 Turkey Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 257 Turkey Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 258 Turkey Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 259 Turkey Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 260 Turkey Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 261 Iraq Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 262 Iraq Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 263 Iraq Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 264 Iraq Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 265 Iraq Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)
  • Table 266 Morocco Meningococcal Vaccines Market, By Type 2017 - 2030 (USD Million)
  • Table 267 Morocco Meningococcal Vaccines Market, By Brand 2017 - 2030 (USD Million)
  • Table 268 Morocco Meningococcal Vaccines Market, By Age Group 2017 - 2030 (USD Million)
  • Table 269 Morocco Meningococcal Vaccines Market, By Serotype 2017 - 2030 (USD Million)
  • Table 270 Morocco Meningococcal Vaccines Market, By Sales Channel 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Meningococcal vaccines market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Meningococcal vaccines market snapshot
  • Fig. 10 Key market opportunities
  • Fig. 11 Meningococcal vaccines market driver impact
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Strategy mapping
  • Fig. 16 Meningococcal vaccines market: Type movement analysis
  • Fig. 17 Meningococcal vaccines: Type segment dashboard
  • Fig. 18 Meningococcal vaccines market type outlook: Key takeaways
  • Fig. 19 Bivalent market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 20 Quadrivalent market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 21 Others market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 22 Meningococcal vaccines market: Brand movement analysis
  • Fig. 23 Meningococcal vaccines: Brand segment dashboard
  • Fig. 24 Meningococcal vaccines market Brand outlook: Key takeaways
  • Fig. 25 Menactra market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 26 Menveo market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 27 Nimenrix market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 28 Trumenba market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 29 Bexsero market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 30 Others market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 31 Meningococcal vaccines market: Age group movement analysis
  • Fig. 32 Meningococcal vaccines: Age group segment dashboard
  • Fig. 33 Meningococcal vaccines market age group outlook: Key takeaways
  • Fig. 34 Infants (0-2 years) market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 35 Children and adults (2 years and above) market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 36 Meningococcal vaccines market: Serotype movement analysis
  • Fig. 37 Meningococcal vaccines: Serotype segment dashboard
  • Fig. 38 Meningococcal vaccines market Serotype outlook: Key takeaways
  • Fig. 39 Serotype A market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 40 Serotype B market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 41 Serotype C market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 42 Serotype W-135 market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 43 Serotype Y market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 44 Meningococcal vaccines market: Sales channel movement analysis
  • Fig. 45 Meningococcal vaccines: Sales channel segment dashboard
  • Fig. 46 Meningococcal vaccines market Sales channel outlook: Key takeaways
  • Fig. 47 Private market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 48 Public market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 49 Regional outlook, 2019 & 2027
  • Fig. 50 Regional market dashboard
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America
  • Fig. 53 North America market estimates and forecast 2017 - 2030 ( USD Million)
  • Fig. 54 U.S.
  • Fig. 55 U.S. market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 56 Canada
  • Fig. 57 Canada market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 58 Europe
  • Fig. 59 Europe market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 60 Germany
  • Fig. 61 Germany market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 62 U.K.
  • Fig. 63 U.K. market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 64 France
  • Fig. 65 France market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 66 Spain
  • Fig. 67 Spain market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 68 Italy
  • Fig. 69 Italy market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 70 Russia
  • Fig. 71 Russia market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 72 Belarus
  • Fig. 73 Belarus market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 74 Georgia
  • Fig. 75 Georgia market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 76 Moldova
  • Fig. 77 Moldova market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 78 Asia Pacific
  • Fig. 79 Asia Pacific market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 80 Japan
  • Fig. 81 Japan market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 82 China
  • Fig. 83 China market estimates and forecasts, 2017-2030
  • Fig. 84 India
  • Fig. 85 India market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 86 South Korea
  • Fig. 87 South Korea market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 88 Australia
  • Fig. 89 Australia market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 90 Singapore
  • Fig. 91 Singapore market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 92 Thailand
  • Fig. 93 Thailand market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 94 Vietnam
  • Fig. 95 Vietnam market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 96 Malaysia
  • Fig. 97 Malaysia market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 98 Indonesia
  • Fig. 99 Indonesia market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 100 Kazakhstan
  • Fig. 101 Kazakhstan market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 102 Kyrgyzstan
  • Fig. 103 Kyrgyzstan market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 104 Armenia
  • Fig. 105 Armenia market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 106 Azerbaijan
  • Fig. 107 Azerbaijan market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 108 Tajikistan
  • Fig. 109 Tajikistan market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 110 Turkmenistan
  • Fig. 111 Turkmenistan market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 112 Uzbekistan
  • Fig. 113 Uzbekistan market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 114 Latin America
  • Fig. 115 Latin America market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 116 Brazil
  • Fig. 117 Brazil market estimates and forecasts 2017 - 2030 ( USD Million)
  • Fig. 118 Mexico
  • Fig. 119 Mexico market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 120 Argentina
  • Fig. 121 Argentina market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 122 Chile
  • Fig. 123 Chile market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 124 Cuba
  • Fig. 125 Cuba market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 126 Ecuador
  • Fig. 127 Ecuador market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 128 Peru
  • Fig. 129 Peru market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 130 Colombia
  • Fig. 131 Colombia market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 132 Venezuela
  • Fig. 133 Venezuela market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 134 Middle East & Africa
  • Fig. 135 Middle East and Africa market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 136 South Africa
  • Fig. 137 South Africa market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 138 Saudi Arabia
  • Fig. 139 Saudi Arabia market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 140 UAE
  • Fig. 141 UAE market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 142 Algeria
  • Fig. 143 Algeria market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 144 Egypt
  • Fig. 145 Egypt market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 146 Tunisia
  • Fig. 147 Tunisia market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 148 Iran
  • Fig. 149 Iran market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 150 Turkey
  • Fig. 151 Turkey market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 152 Iraq
  • Fig. 153 Iraq market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 154 Morocco
  • Fig. 155 Morocco market estimates and forecasts 2017 - 2030 (USD Million)
  • Fig. 156 Ansoff Matrix
  • FIg. 157 Competition Categorization
  • FIg. 158 Company market share analysis
  • Fig. 159 Company market position analysis
  • Fig. 160 Company market position analysis
  • Fig. 161 Competitive dashboard analysis
  • Fig. 162 Regional Network Map
  • FIg. 163 Strategy Framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!